Maximum Daily Dose of Depakote DR
The maximum recommended daily dose of Depakote DR (delayed-release divalproex sodium) is 60 mg/kg/day across all approved indications, including epilepsy and mania. 1
FDA-Approved Maximum Dosing
The FDA drug label explicitly states that no recommendation regarding the safety of valproate for use at doses above 60 mg/kg/day can be made 1. This ceiling applies to:
- Complex partial seizures (monotherapy or adjunctive): Maximum 60 mg/kg/day
- Absence seizures: Maximum 60 mg/kg/day
- Acute mania: Maximum 60 mg/kg/day
Indication-Specific Dosing Ranges
Migraine Prophylaxis
For migraine prevention in adults, the dosing is more restrictive:
The guidelines consistently recommend divalproex sodium at 500 to 1500 mg/day for migraine prevention 2, 3. While the FDA label focuses on the 500-1000 mg range for Depakote ER specifically, the delayed-release formulation (Depakote DR) has established efficacy up to 1500 mg/day in clinical practice.
Epilepsy
- Initial: 10-15 mg/kg/day
- Titration: Increase by 5-10 mg/kg/week
- Target: Optimal response typically achieved below 60 mg/kg/day
- Absolute maximum: 60 mg/kg/day 1
Acute Mania
- Initial: 25 mg/kg/day
- Maximum: 60 mg/kg/day 1
Critical Safety Considerations
Dose-related toxicity increases significantly at higher doses. The probability of thrombocytopenia rises substantially at total valproate concentrations ≥110 mcg/mL (females) or ≥135 mcg/mL (males) 1. Elevated liver enzymes are also dose-dependent.
For elderly patients, start with doses lower than 250 mg (requiring use of standard Depakote rather than ER formulation) and titrate slowly with close monitoring for somnolence, dehydration, and decreased food/fluid intake 1.
Therapeutic Drug Monitoring
The usually accepted therapeutic plasma concentration range is 50-100 mcg/mL 1. If satisfactory clinical response is not achieved at doses below 60 mg/kg/day, check plasma levels before considering the medication ineffective.
Important Formulation Note
Depakote DR should NOT be crushed or chewed as this destroys the delayed-release coating designed to minimize gastric irritation 1. For patients requiring dose adjustments smaller than available with Depakote ER, use standard Depakote DR instead 1.